Healthcare | August 03, 2021
Healthium Medtech acquires SGK Lab’s AbGel gelatin business
Complementary business models are the reason for the acquisition
Complementary business models are the reason for the acquisition
The company has predominantly built a portfolio into veterinary products
The study was conducted in patients with mild to moderate COVID-19
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
_256_384.jpeg)
Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states
The company is expecting tremendous growth and a better quarterly performance
Subscribe To Our Newsletter & Stay Updated
